Breast cancer and mental health: How to manage depression, anxiety, and treatment challenges
"I, Ovosan" offers inspiring cancer survivor stories interwoven with cutting-edge research, detailing the development and therapeutic potential of Ovosan's bioactive phospholipids, now available in the US as CellBB.
In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” gene, ZNFX1, that may act as a biomarker to help guide treatment in future clinical trials involving patients with therapy-resistant ovarian cancer, according to a study recently published in Cancer Research.
Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB’s 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society’s (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS’ flagship annual meeting, will be held April 24–27 in Baltimore.
At the start of the pandemic, Iona Woolmington was installing artwork at a contemporary art museum in downtown Chicago when she first began having trouble in the bathroom. Blood in her stool prompted the then 35-year-old to see a doctor, leading to a devastating diagnosis: stage 3 rectal cancer.
Susan G. Komen®, the world’s leading breast cancer organization, commends Senators Tan Parker (R-Flower Mound) and Carol Alvarado (D-Houston) for introducing legislation that would eliminate financial barriers to clinically appropriate genetic testing and supplemental breast imaging. In Texas, more than 23,880 people will be diagnosed with breast cancer and more than 3,330 are expected to die of the disease in 2025 alone.
Susan G. Komen®, the world’s leading breast cancer organization commends Senators Linda Greenstein (D-Middlesex) and Britnee N. Timberlake (D-East Orange) and Assemblymembers Lisa Swain (D-Fair Lawn) and Margie Donlon, M.D., (D-Ocean Township) for working with Komen to ensure that everyone has equitable access to diagnostic and supplemental breast imaging, by eliminating the financial barriers patients face in accessing needed breast cancer screening.
A Rutgers biochemistry professor explains how omega-6 fatty acids found in Western diets can activate cellular growth pathways in certain breast cancers.
Learn more about FITWISE at RWJBarnabas Health and Rutgers Cancer Institute, an innovative clinical trial aiming to induce sustainable weight loss, improve cardiometabolic health and potentially reduce cancer recurrence during the survivorship years of patients with early-stage hormone receptor positive/Her 2 negative (HR+/Her2-) breast cancer.
Extended nails and false eyelashes are putting female basketball players at an even higher risk for eye injuries on the court and possible sight-threatening infections, says the American Academy of Ophthalmology.
As a cancer patient, it can be challenging to ask questions of your health care providers. Even though I am a trained journalist who practically asks questions for a living, I struggled with all the questions I had during the early parts of my cancer journey.
Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment, according to new data from researchers at The University of Texas MD Anderson Cancer Center.
Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company Pfizer to support an innovative new program designed to bolster early cancer detection and prevention efforts. The donation will help build a bridge bringing research discoveries to community health centers and improving access to early detection tests for colorectal, breast, cervical and prostate cancer.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
For women with early-stage breast cancer, breast-conserving therapy (BCT) including radiation therapy (RT) leads to progressive reduction in breast size over time, reports a study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
BACKGROUNDCervical cancer (CC) stem cell-like cells (CCSLCs), defined by the capacity of differentiation and self-renewal and proliferation, play a significant role in the progression of CC. However, the molecular mechanisms regulating thei
Make A Difference for Cervical Cancer Research By Participating in the 14th Annual Susan Zabransky Hughes Memorial 5K Run/Walk on April 26
Initiative aims to transform Guyana’s public health system by 2030 with world-class healthcare services accessible to all citizens, especially vulnerable communities
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right